1. Cancer Chemoprevention: A Strategic Approach Using Phytochemicals
   Mohan Shankar G. et al, 2022, Frontiers in Pharmacology CrossRef
2. Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer
   Wenli Liu et al, 2024, Nutrients CrossRef
3. Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy
   Milad Ashrafizadeh et al, 2021, Carbohydrate Polymers CrossRef
4. Emodin: A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets
   Hardeep Singh Tuli et al, 2021, Toxicology in Vitro CrossRef
5. Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
   Sepideh Mirzaei et al, 2021, Cells CrossRef
6. Ginsenoside Rb1 for overcoming cisplatin-insensitivity of A549/DDP cells in vitro and vivo through the dual-inhibition on two efflux pumps of ABCB1 and PTCH1
   Xueni Niu et al, 2023, Phytomedicine CrossRef
7. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
   Milad Ashrafizadeh et al, 2024, Environmental Research CrossRef
8. Therapeutic Potential of Emodin for Gastrointestinal Cancers
   Sierra J. McDonald et al, 2022, Integrative Cancer Therapies CrossRef
9. The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb—A Summary Update
   Monika Stompor-Gorący, 2021, International Journal of Molecular Sciences CrossRef
10. Combination Anticancer Therapies Using Selected Phytochemicals
    Wamidh H. Talib et al, 2022, Molecules CrossRef
11. Targeting Drug Chemo-Resistance in Cancer Using Natural Products
    Wamidh H. Talib et al, 2021, Biomedicines CrossRef
12. Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer
    Yuan Gao et al, 2024, Current Cancer Drug Targets CrossRef
13. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
    Sepideh Mirzaei et al, 2022, Drug Discovery Today CrossRef